 | • レポートコード：20QY06-07273 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、単純ヘルペスウイルス（HSV）ワクチンのグローバル市場について種類別（GEN-003、VCL-HB01、HSV529、その他）、用途別（HSV-1（口腔ヘルペス）、HSV-2（性器ヘルペス））、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・単純ヘルペスウイルス（HSV）ワクチン市場の概要 ・世界の主要地域別単純ヘルペスウイルス（HSV）ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の単純ヘルペスウイルス（HSV）ワクチン市場規模2015-2026：種類別（GEN-003、VCL-HB01、HSV529、その他） ・世界の単純ヘルペスウイルス（HSV）ワクチン市場規模2015-2026：用途別（HSV-1（口腔ヘルペス）、HSV-2（性器ヘルペス）） ・単純ヘルペスウイルス（HSV）ワクチンの北米市場規模2015-2020 ・単純ヘルペスウイルス（HSV）ワクチンのヨーロッパ市場規模2015-2020 ・単純ヘルペスウイルス（HSV）ワクチンの中国市場規模2015-2020 ・単純ヘルペスウイルス（HSV）ワクチンの日本市場規模2015-2020 ・単純ヘルペスウイルス（HSV）ワクチンの東南アジア市場規模2015-2020 ・単純ヘルペスウイルス（HSV）ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、GlaxoSmithKline、Genocea Biosciences、Vical） ・単純ヘルペスウイルス（HSV）ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・単純ヘルペスウイルス（HSV）ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Herpes Simplex Virus (HSV) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Herpes Simplex Virus (HSV) Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Herpes Simplex Virus (HSV) Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Herpes Simplex Virus (HSV) Vaccines industry.
Based on our recent survey, we have several different scenarios about the Herpes Simplex Virus (HSV) Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Herpes Simplex Virus (HSV) Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Herpes Simplex Virus (HSV) Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Herpes Simplex Virus (HSV) Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Herpes Simplex Virus (HSV) Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Herpes Simplex Virus (HSV) Vaccines market. The report also includes nautical information, where it shows Herpes Simplex Virus (HSV) Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Herpes Simplex Virus (HSV) Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Herpes Simplex Virus (HSV) Vaccines market.
Geographical Analysis:
Based on region, the global Herpes Simplex Virus (HSV) Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Herpes Simplex Virus (HSV) Vaccines market are
Sanofi
GlaxoSmithKline
Genocea Biosciences
Vical
…
Segment by Type
GEN-003
VCL-HB01
HSV529
Others
Segment by Application
HSV-1 (Oral Herpes)
HSV-2 (Genital Herpes)
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Herpes Simplex Virus (HSV) Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Herpes Simplex Virus (HSV) Vaccines market.
• The market share of the global Herpes Simplex Virus (HSV) Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Herpes Simplex Virus (HSV) Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Herpes Simplex Virus (HSV) Vaccines market.
1 Herpes Simplex Virus (HSV) Vaccines Market Overview
1.1 Herpes Simplex Virus (HSV) Vaccines Product Scope
1.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type
1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2026)
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Herpes Simplex Virus (HSV) Vaccines Segment by Application
1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Comparison by Application (2020-2026)
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Herpes Simplex Virus (HSV) Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Herpes Simplex Virus (HSV) Vaccines Industry
1.5.1.1 Herpes Simplex Virus (HSV) Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Herpes Simplex Virus (HSV) Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Herpes Simplex Virus (HSV) Vaccines Players to Combat Covid-19 Impact
2 Herpes Simplex Virus (HSV) Vaccines Estimate and Forecast by Region
2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2015-2026)
2.4.3 China Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2015-2026)
2.4.6 India Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2015-2026)
3 Global Herpes Simplex Virus (HSV) Vaccines Competition Landscape by Players
3.1 Global Top Herpes Simplex Virus (HSV) Vaccines Players by Sales (2015-2020)
3.2 Global Top Herpes Simplex Virus (HSV) Vaccines Players by Revenue (2015-2020)
3.3 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2019)
3.4 Global Herpes Simplex Virus (HSV) Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Herpes Simplex Virus (HSV) Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Herpes Simplex Virus (HSV) Vaccines Players (Opinion Leaders)
4 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Type
4.1 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2014-2020)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Type (2021-2026)
5 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Application
5.1 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2015-2020)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Application (2021-2026)
3 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
3.2 North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
4 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
4.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
5 China Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
5.2 China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
5.3 China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
5.4 China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
6 Japan Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
6.2 Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
7.2 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
8 India Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
8.2 India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
8.3 India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
8.4 India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Herpes Simplex Virus (HSV) Vaccines Business
12.1 Sanofi
12.1.1 Sanofi Herpes Simplex Virus (HSV) Vaccines Corporation Information
12.1.2 Sanofi Herpes Simplex Virus (HSV) Vaccines Business Overview and Total Revenue
12.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Products Offered
12.1.5 Sanofi Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Corporation Information
12.2.2 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Business Overview and Total Revenue
12.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Genocea Biosciences
12.3.1 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Corporation Information
12.3.2 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Business Overview and Total Revenue
12.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Products Offered
12.3.5 Genocea Biosciences Recent Development
12.4 Vical
12.4.1 Vical Herpes Simplex Virus (HSV) Vaccines Corporation Information
12.4.2 Vical Herpes Simplex Virus (HSV) Vaccines Business Overview and Total Revenue
12.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Products Offered
12.4.5 Vical Recent Development
…
13 Herpes Simplex Virus (HSV) Vaccines Manufacturing Cost Analysis
13.1 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
13.4 Herpes Simplex Virus (HSV) Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Herpes Simplex Virus (HSV) Vaccines Distributors List
14.3 Herpes Simplex Virus (HSV) Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Herpes Simplex Virus (HSV) Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Herpes Simplex Virus (HSV) Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Herpes Simplex Virus (HSV) Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Herpes Simplex Virus (HSV) Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Region (2015-2020)
Table 10. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Herpes Simplex Virus (HSV) Vaccines (K Units) of Key Companies (2015-2020)
Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Company (2015-2020)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2019)
Table 22. Global Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Herpes Simplex Virus (HSV) Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Herpes Simplex Virus (HSV) Vaccines Players
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2015-2020)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Price (K Units) by Type (2015-2020)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2021-2026)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Price (K Units) by Type (2021-2026)
Table 35. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2015-2020)
Table 36. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2015-2020)
Table 37. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Herpes Simplex Virus (HSV) Vaccines Price (K Units) by Application (2015-2020)
Table 39. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2021-2026)
Table 40. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2021-2026)
Table 41. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Herpes Simplex Virus (HSV) Vaccines Price (K Units) by Application (2021-2026)
Table 44. United States Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2015-2020)
Table 45. United States Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 47. United States Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2015-2020)
Table 49. United States Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2015-2020)
Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 53. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2015-2020)
Table 55. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2015-2020)
Table 57. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 59. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2015-2020)
Table 61. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2015-2020)
Table 63. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 65. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2015-2020)
Table 67. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2015-2020)
Table 75. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2015-2020)
Table 77. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2015-2020)
Table 79. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Herpes Simplex Virus (HSV) Vaccines Product
Table 84. Sanofi Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Genocea Biosciences Corporation Information
Table 91. Genocea Biosciences Description and Business Overview
Table 92. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product
Table 94. Genocea Biosciences Recent Development
Table . Vical Corporation Information
Table . Vical Description and Business Overview
Table . Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Vical Herpes Simplex Virus (HSV) Vaccines Product
Table . Vical Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 103. Herpes Simplex Virus (HSV) Vaccines Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Simplex Virus (HSV) Vaccines Product Picture
Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2020 & 2026
Figure 6. HSV-1 (Oral Herpes) Examples
Figure 7. HSV-2 (Genital Herpes) Examples
Figure 8. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Herpes Simplex Virus (HSV) Vaccines Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue in Herpes Simplex Virus (HSV) Vaccines 2015 & 2019
Figure 26. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2015-2020)
Figure 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2015-2020)
Figure 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 32. United States Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 33. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2019
Figure 36. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company in 2019
Figure 37. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 38. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2019
Figure 39. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 41. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2019
Figure 45. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company in 2019
Figure 46. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 47. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2019
Figure 48. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Genocea Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Vical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Herpes Simplex Virus (HSV) Vaccines
Figure 54. Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
Figure 55. Herpes Simplex Virus (HSV) Vaccines Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
口唇ヘルペス（口腔ヘルペス）薬の世界市場レポート2020 Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the …- 性感染症（STD）診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Sexually Transmitted Disease (STD) Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- ウイルスフィルターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Virus Filters market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Virus Filters market report pro…
- エボラウイルスワクチンの世界市場レポート2020 Market Analysis and Insights: Global Ebola Virus Vaccine Market The global Ebola Virus Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Ebola Virus Vaccine Scope and Market Size The global Ebola Vi…
- ジカウイルスの世界市場レポート2020 A recently published report by QY Research titled Global Zika Virus Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in…